Definitive Healthcare (DH) Stock Price

Definitive Healthcare Price

NASDAQ·CLOSED
0.69USD+0.0078 (+1.13 %)
Market closed

Over the last 6 years Definitive Healthcare grew revenue by 18.9% annually, reaching 241.52 M USD. For Definitive Healthcare, the net margin of -57.5% is down versus -31.2% a few years ago. The consensus 12-month price target for Definitive Healthcare is 3.83 USD, about 451.4% above where the stock trades today. Of 20 analysts, 10 rate the stock a buy — an overall Buy consensus. The stock trades about 10% above its 52-week low.

Definitive Healthcare stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Definitive Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Definitive Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Definitive Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Definitive Healthcare Stock Price History
DateDefinitive Healthcare Price
7/27/20260.69 USD
7/23/20260.69 USD
7/22/20260.70 USD
7/21/20260.73 USD
7/20/20260.72 USD
7/17/20260.76 USD
7/16/20260.82 USD
7/15/20260.81 USD
7/14/20260.85 USD
7/13/20260.82 USD
7/10/20260.84 USD
7/9/20260.80 USD
7/8/20260.82 USD
7/7/20260.90 USD
7/6/20260.76 USD
7/2/20260.78 USD
7/1/20260.80 USD
6/30/20260.83 USD
6/29/20260.72 USD
6/26/20260.66 USD
6/25/20260.63 USD
6/24/20260.76 USD
6/23/20260.74 USD
6/22/20260.76 USD
6/18/20260.76 USD
6/17/20260.79 USD
6/16/20260.81 USD
6/15/20260.80 USD
6/12/20260.84 USD
6/11/20260.85 USD
6/10/20260.83 USD
6/9/20260.85 USD
6/8/20260.85 USD
6/5/20260.90 USD
6/4/20260.91 USD
6/3/20260.88 USD
6/2/20260.96 USD
6/1/20260.99 USD
5/29/20260.93 USD
5/28/20260.89 USD
5/27/20260.86 USD
5/26/20260.90 USD
5/22/20260.85 USD
5/21/20260.82 USD
5/20/20260.86 USD
5/19/20260.87 USD
5/18/20260.84 USD
5/15/20260.81 USD
5/14/20260.86 USD
5/13/20260.89 USD
5/12/20260.93 USD
5/11/20260.99 USD
5/8/20260.95 USD
5/7/20260.92 USD
5/6/20260.94 USD
5/5/20260.96 USD
5/4/20261.03 USD
5/1/20260.99 USD
4/30/20260.95 USD
4/29/20260.94 USD
4/28/20261.01 USD
4/27/20261.01 USD
4/24/20261.02 USD
4/23/20261.00 USD
4/22/20261.12 USD
4/21/20261.05 USD
4/20/20261.05 USD
4/17/20261.03 USD
4/16/20261.05 USD
4/15/20261.08 USD
4/14/20261.01 USD
4/13/20260.99 USD
4/10/20260.95 USD
4/9/20260.97 USD
4/8/20261.04 USD
4/7/20261.07 USD
4/6/20261.10 USD
4/2/20261.08 USD
4/1/20261.09 USD
3/31/20261.23 USD
3/30/20261.16 USD
3/27/20261.05 USD
3/26/20261.09 USD
3/25/20261.09 USD
3/24/20261.11 USD
3/23/20261.19 USD
3/20/20261.13 USD
3/19/20261.00 USD
3/18/20261.07 USD
3/17/20261.12 USD
3/16/20261.10 USD
3/13/20261.13 USD
3/12/20261.13 USD
3/11/20261.19 USD
3/10/20261.20 USD
3/9/20261.24 USD
3/6/20261.18 USD
3/5/20261.22 USD
3/4/20261.22 USD
3/3/20261.16 USD
3/2/20261.14 USD
2/27/20261.28 USD
2/26/20261.40 USD
2/25/20261.41 USD
2/24/20261.39 USD
2/23/20261.38 USD
2/20/20261.51 USD
2/19/20261.57 USD
2/18/20261.57 USD
2/17/20261.56 USD
2/13/20261.59 USD
2/12/20261.54 USD
2/11/20261.69 USD
2/10/20261.89 USD
2/9/20261.89 USD
2/6/20261.99 USD
2/5/20261.96 USD
2/4/20262.05 USD
2/3/20262.17 USD
2/2/20262.34 USD
1/30/20262.32 USD
1/29/20262.28 USD
1/28/20262.36 USD
1/27/20262.39 USD
1/26/20262.44 USD
1/23/20262.43 USD
1/22/20262.48 USD
1/21/20262.38 USD
1/20/20262.27 USD
1/16/20262.39 USD
1/15/20262.43 USD
1/14/20262.46 USD
1/13/20262.47 USD
1/12/20262.54 USD
1/9/20262.55 USD
1/8/20262.57 USD
1/7/20262.56 USD
1/6/20262.54 USD
1/5/20262.46 USD
1/2/20262.38 USD
12/31/20252.87 USD
12/30/20252.79 USD
12/29/20252.71 USD
12/26/20252.63 USD
12/24/20252.62 USD
12/23/20252.52 USD
12/22/20252.53 USD
12/19/20252.54 USD
12/18/20252.58 USD
12/17/20252.28 USD
12/16/20252.29 USD
12/15/20252.30 USD
12/12/20252.31 USD
12/11/20252.30 USD
12/10/20252.38 USD
12/9/20252.37 USD
12/8/20252.45 USD
12/5/20252.48 USD
12/4/20252.56 USD
12/3/20252.59 USD
12/2/20252.65 USD
12/1/20252.66 USD
11/28/20252.84 USD
11/26/20252.81 USD
11/25/20252.80 USD
11/24/20252.69 USD
11/21/20252.76 USD
11/20/20252.60 USD
11/19/20252.58 USD
11/18/20252.60 USD
11/17/20252.62 USD
11/14/20252.74 USD
11/13/20252.72 USD
11/12/20252.72 USD
11/11/20252.87 USD
11/10/20252.85 USD
11/7/20252.93 USD
11/6/20252.65 USD
11/5/20252.72 USD
11/4/20252.78 USD
11/3/20252.86 USD
10/31/20252.77 USD
10/30/20252.68 USD
10/29/20252.77 USD
10/28/20252.94 USD
10/27/20252.97 USD
10/24/20252.97 USD
10/23/20252.95 USD
10/22/20252.94 USD
10/21/20252.97 USD
10/20/20253.04 USD
10/17/20252.87 USD
10/16/20252.93 USD
10/15/20252.99 USD
10/14/20253.03 USD
10/13/20252.99 USD
10/10/20252.87 USD
10/9/20253.08 USD
10/8/20253.23 USD
10/7/20253.19 USD
10/6/20253.41 USD
10/3/20253.42 USD
10/2/20253.33 USD
10/1/20253.56 USD
9/30/20254.06 USD
9/29/20254.04 USD
9/26/20253.98 USD
9/25/20253.85 USD
9/24/20253.92 USD
9/23/20254.17 USD
9/22/20254.30 USD
9/19/20254.21 USD
9/18/20254.28 USD
9/17/20254.09 USD
9/16/20254.09 USD
9/15/20254.05 USD
9/12/20254.15 USD
9/11/20254.13 USD
9/10/20253.98 USD
9/9/20254.14 USD
9/8/20254.15 USD
9/5/20254.00 USD
9/4/20254.01 USD
9/3/20253.89 USD
9/2/20253.81 USD
8/29/20254.03 USD
8/28/20254.01 USD
8/27/20254.04 USD
8/26/20253.91 USD
8/25/20253.99 USD
8/22/20254.06 USD
8/21/20253.77 USD
8/20/20253.72 USD
8/19/20253.79 USD
8/18/20253.93 USD
8/15/20253.87 USD
8/14/20253.80 USD
8/13/20253.94 USD
8/12/20253.60 USD
8/11/20253.52 USD
8/8/20253.86 USD
8/7/20253.97 USD
8/6/20253.93 USD
8/5/20253.88 USD
8/4/20253.84 USD
8/1/20253.74 USD
7/31/20253.90 USD
7/30/20254.00 USD
Access this data via the Eulerpool API
Get Free API Key

Definitive Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
166.15 M USD
-36.90 M USD
-51.91 M USD
Jan 1, 2022
222.65 M USD
-44.04 M USD
-7.22 M USD
Jan 1, 2023
251.42 M USD
-329.80 M USD
-202.39 M USD
Jan 1, 2024
252.20 M USD
-710.82 M USD
-413.12 M USD
Jan 1, 2025
241.52 M USD
-197.97 M USD
-138.93 M USD
Jan 1, 2026 (e)
223.43 M USD
-142.07 M USD
19.72 M USD
Jan 1, 2027 (e)
222.77 M USD
-141.65 M USD
19.79 M USD
Jan 1, 2028 (e)
241.42 M USD
-153.51 M USD
25.60 M USD

Definitive Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 30, 2026, 9:13 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e
85.00118.00166.00222.00251.00252.00241.00223.00222.00241.00
–38.8240.6833.7313.060.40-4.37-7.47-0.458.56
49.4173.7375.3081.0880.8878.1775.9375.9375.9375.93
42.0087.00125.00180.00203.00197.00183.00169.33168.57183.00
-2.00-16.00-36.00-44.00-329.00-710.00-197.00-142.00-141.00-153.00
-2.35-13.56-21.69-19.82-131.08-281.75-81.74-63.68-63.51-63.49
-36.00-52.00-51.00-7.00-202.00-413.00-138.0019.0019.0025.00
–44.44-1.92-86.272,785.71104.46-66.59-113.77–31.58
103.3687.5292.55102.01116.42115.02103.36103.36103.36103.36
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Definitive Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Definitive Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Definitive Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Definitive Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Definitive Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Definitive Healthcare stock margins

The Definitive Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Definitive Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Definitive Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
75.51 %
-22.21 %
-31.24 %
Jan 1, 2022
80.86 %
-19.78 %
-3.24 %
Jan 1, 2023
81.11 %
-131.18 %
-80.50 %
Jan 1, 2024
78.30 %
-281.85 %
-163.81 %
Jan 1, 2025
75.88 %
-81.97 %
-57.52 %
Jan 1, 2026 (e)
75.88 %
-63.59 %
8.82 %
Jan 1, 2027 (e)
75.88 %
-63.59 %
8.88 %
Jan 1, 2028 (e)
75.88 %
-63.59 %
10.60 %

Definitive Healthcare Stock Revenue, EBIT, Earnings per Share

The Definitive Healthcare earnings per share therefore indicates how much revenue Definitive Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.80 USD
-0.40 USD
-0.56 USD
Jan 1, 2022
2.18 USD
-0.43 USD
-0.07 USD
Jan 1, 2023
2.16 USD
-2.83 USD
-1.74 USD
Jan 1, 2024
2.19 USD
-6.18 USD
-3.59 USD
Jan 1, 2025
2.34 USD
-1.92 USD
-1.34 USD
Jan 1, 2026 (e)
2.10 USD
-1.37 USD
0.18 USD
Jan 1, 2027 (e)
2.09 USD
-1.37 USD
0.19 USD
Jan 1, 2028 (e)
2.26 USD
-1.49 USD
0.24 USD

Definitive Healthcare business model & stock analysis

Definitive Healthcare Corp is a leading provider of software and information for companies in the healthcare industry. The company was founded in 2011 and is headquartered in Framingham, Massachusetts. Since its founding, the company has become one of the major providers of data and analysis in the healthcare industry. The business model of Definitive Healthcare is based on providing comprehensive information and analysis for companies operating in the healthcare industry. This includes pharmaceutical and medical technology companies, as well as hospitals, clinics, and insurance companies. With the help of Definitive Healthcare's data and analysis, these companies can make better decisions and develop informed strategies. Definitive Healthcare is divided into different segments to meet the varying needs of its customers. One of these segments is the provider segment, where information about healthcare facilities is collected and provided. Another segment is the pharmaceutical and biotech segment, where pharmaceutical companies can learn more about their customers and their needs. For the medical technology segment, information and analysis on the habits of their customers are provided. Definitive Healthcare offers a variety of products that make it easier for its customers to achieve their business goals. One of the company's most important products is the Definitive Healthcare Platform Dashboard. The dashboard provides a comprehensive overview of the entire healthcare market and informs about the latest trends and developments. Another important product is the Definitive Medtech Suite, a platform that provides analysis and information for the medical technology segment. Other products of Definitive Healthcare include the Definitive Pharmacy & Clinical Suite, which provides information and analysis for the pharmaceutical and biotech segment. The suite also includes a database of information on drugs and their usage. Another important product is the Definitive Hospital Insights Suite, which contains information about hospitals and healthcare facilities. Definitive Healthcare has gained a good reputation in the industry and is now one of the major providers of data and analysis in the healthcare industry. The company is constantly striving to improve its products and services and provide its customers with a useful and relevant source of information. The focus of Definitive Healthcare is on providing data and analysis that help companies in the industry make informed decisions and achieve their business goals.

Definitive Healthcare SWOT Analysis

Strengths

Definitive Healthcare Corp possesses a strong market reputation and brand recognition, which contributes to its competitive advantage.

The company has a comprehensive and accurate healthcare database with extensive coverage, enabling it to offer valuable insights to clients.

Definitive Healthcare Corp has a skilled and experienced workforce, allowing the company to provide high-quality and reliable services.

Excellent customer relationships and a large customer base contribute to the company's financial stability and growth.

Weaknesses

Definitive Healthcare Corp may face challenges in keeping its database up to date and accurate due to the constantly changing healthcare landscape.

The company's heavy reliance on technology increases the risk of disruptions or data breaches, potentially impacting its reputation and customer trust.

Being focused on healthcare data, Definitive Healthcare Corp may be vulnerable to regulatory changes and compliance issues that could affect its operations.

The company's pricing structure might be a weakness compared to competitors offering similar services at lower costs.

Opportunities

The increasing demand for healthcare analytics presents an opportunity for Definitive Healthcare Corp to expand its customer base and revenue.

Expanding into new geographic markets or targeting specific segments within the healthcare industry holds potential for growth and diversification.

The adoption of advanced technologies, such as artificial intelligence and machine learning, can enhance the company's data analysis capabilities and provide a competitive edge.

Collaboration with healthcare providers, government agencies, and research organizations can create opportunities for partnerships and data sharing to enhance the company's offerings.

Threats

The emergence of new competitors in the healthcare analytics market poses a potential threat to Definitive Healthcare Corp's market share and growth.

Data privacy concerns and stricter regulations regarding the use and storage of sensitive healthcare information may impact the company's operations and reputation.

Changes in government policies and healthcare regulations could have a significant impact on Definitive Healthcare Corp's business model and revenue streams.

Economic downturns or budget constraints in the healthcare industry may lead to reduced spending on data analytics services, affecting the company's financial performance.

Definitive Healthcare Segments

Definitive Healthcare Revenue by Segment

  • 3 Years

  • Max

Subscription services member
Subscription Services
Platform Subscriptions
Professional Services
Details
Date
Subscription services member
Subscription Services
Platform Subscriptions
Professional Services
Jan 1, 2021
0.00 USD
0.00 USD
164.56 M USD
1.59 M USD
Jan 1, 2022
0.00 USD
217.02 M USD
0.00 USD
5.63 M USD
Jan 1, 2024
244.89 M USD
0.00 USD
0.00 USD
7.32 M USD
Jan 1, 2025
232.23 M USD
0.00 USD
0.00 USD
9.30 M USD

Definitive Healthcare Revenue by Region

  • 3 Years

  • Max

United States
International
Details
Date
United States
International
Jan 1, 2021
158.73 M USD
7.43 M USD
Jan 1, 2022
211.73 M USD
10.93 M USD
Jan 1, 2024
241.81 M USD
10.40 M USD
Jan 1, 2025
224.36 M USD
17.16 M USD

Definitive Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Definitive Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Definitive Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Definitive Healthcare shares outstanding

The number of shares of Definitive Healthcare was 103.36 M in 2025. This indicates how many shares Definitive Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
92.55 M Stocks
Jan 1, 2022
102.01 M Stocks
Jan 1, 2023
116.42 M Stocks
Jan 1, 2024
115.02 M Stocks
Jan 1, 2025
103.36 M Stocks
Jan 1, 2026 (e)
103.36 M Stocks
Jan 1, 2027 (e)
103.36 M Stocks
Jan 1, 2028 (e)
103.36 M Stocks

Current Definitive Healthcare forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy50.00 % (10)
Hold45.00 % (9)
Sell5.00 % (1)
12M Price Target
3.83
Last Price
0.73
Currency
USD
12M Return Potential
423.83 %
LTM Return
0 %

Definitive Healthcare Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/12/20260.04USD57.17 MUSD2026 Q2
8/5/20260.04USD57.17 MUSD2026 Q2
5/7/20260.03USD57.07 MUSD2026 Q1
5/6/20260.03USD57.07 MUSD2026 Q1
4/30/20260.03USD57.07 MUSD2026 Q1
2/26/20260.06USD61.36 MUSD2025 Q4
2/19/20260.06USD61.36 MUSD2025 Q4

EESG©

Eulerpool ESG Scorecard© for the Definitive Healthcare stock

59/100
51
Environment
99
Social
28
Governance
E

Environment

20
Scope 1 - Direct Emissions16
Scope 2 - Indirect emissions from purchased energy218
Scope 3 - Indirect emissions within the value chain1,592
Total CO₂ emissions234
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees39
Percentage of women in management—
Percentage of Asian employees10
Share of Asian management6
Percentage of Hispanic/Latino employees5
Hispano/Latino Management share6
Percentage of Black employees4
Black Management Share1
Percentage of white employees80
White Management Share85
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Definitive Healthcare shareholder structure

% Name
58.59648%
Advent International L.P.
Advent International L.P.
5.48301%
Goldman Sachs & Company, Inc.
Goldman Sachs & Company, Inc.
3.33476%
Coop (Kevin)
Coop (Kevin)
2.49916%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
2.29667%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.93874%
D. E. Shaw & Co., L.P.
D. E. Shaw & Co., L.P.
...

Definitive Healthcare Executives and Management Board

KC

Mr. Kevin Coop

(60)

Chief Executive Officer, Director · since 2024

Compensation10.88 M USD
JK

Mr. Jason Krantz

(52)

Founder, Executive Chairman of the Board · since 2011

Compensation10.36 M USD
KJ

Ms. Kate Shamsuddin Jensen

(38)

Chief Operating Officer

Compensation2.72 M USD
SH

Mr. Samuel Hamood

(57)

Independent Director

Compensation221,456.00 USD
SC

Mr. Sastry Chilukuri

(50)

Independent Director

Compensation201,456.00 USD

Frequently asked questions about Definitive Healthcare

Definitive Healthcare Corp's business model revolves around providing comprehensive and accurate data and analytics for the healthcare industry. As a leading provider of healthcare intelligence, Definitive Healthcare Corp offers a wide range of solutions to healthcare organizations, including hospitals, pharmaceutical companies, and medical device manufacturers. By collecting and analyzing vast amounts of healthcare data, Definitive Healthcare Corp enables its clients to make informed decisions, identify market trends, and gain a competitive edge. With its focus on delivering high-quality information, Definitive Healthcare Corp plays a crucial role in helping healthcare organizations improve efficiency, enhance patient care, and drive growth.

All fundamentals and in-depth analysis of Definitive Healthcare

Our stock analysis for Definitive Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Definitive Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Definitive Healthcare Stock
Definitive Healthcare Revenue→
Definitive Healthcare Stock
Definitive Healthcare Net Income→
Definitive Healthcare Stock
Definitive Healthcare P/E→
Definitive Healthcare Stock
Definitive Healthcare P/S→
Definitive Healthcare Stock
Definitive Healthcare EBIT→
Definitive Healthcare Stock
Definitive Healthcare Dividend→
Definitive Healthcare Stock
Definitive Healthcare Directors Dealings→
Definitive Healthcare Stock
Definitive Healthcare Stocks→
Definitive Healthcare Stock
Definitive Healthcare Market capitalization→
Definitive Healthcare Stock
Definitive Healthcare Debt→
Definitive Healthcare Stock
Definitive Healthcare Liabilities→
Definitive Healthcare Stock
Definitive Healthcare Equity→
Definitive Healthcare Stock
Definitive Healthcare AAQS→
Definitive Healthcare Stock
Definitive Healthcare Employees→
Definitive Healthcare Stock
Definitive Healthcare ROE→
Definitive Healthcare Stock
Definitive Healthcare ROA→
Definitive Healthcare Stock
Definitive Healthcare ROCE→
Definitive Healthcare Stock
Definitive Healthcare News→
Definitive Healthcare Stock
Definitive Healthcare Analyst Price Targets→

Health Stocks

Definium TherapeuticsDefence TherapeuticsDelcath SystemsDeepNoidDelivra Health BrandsDedicare AB (publ)Delta Asia InternationalDecoy TherapeuticsDelta-Fly PharmaDecision DiagnosticsDemant A/SDecipher LabsAll Stocks A–Z →